Cyanobacteria are blue-green Gram-negative and photosynthetic bacteria which are seen as one of the most morphologically numerous groups of prokaryotes. Because of their ability to fix gaseous nitrogen and carbon dioxide to organic materials, they are known to play important roles in the universal nutrient cycle. Cyanobacteria has emerged as one of the promising resources to combat the issues of global warming, disease outbreaks, nutrition insecurity, energy crises as well as persistent daily human population increases. Cyanobacteria possess significant levels of macro and micronutrient substances which facilitate the versatile popularity to be utilized as human food and protein supplements in many countries such as Asia. Cyanobacteria has been employed as a complementary dietary constituent of feed for poultry and as vitamin and protein supplement in aquatic lives. They are effectively used to deal with numerous tasks in various fields of biotechnology, such as agricultural (including aquaculture), industrial (food and dairy products), environmental (pollution control), biofuel (bioenergy) and pharmaceutical biotechnology (such as antimicrobial, anti-inflammatory, immunosuppressant, anticoagulant and antitumor); recently, the growing interest of applying them as biocatalysts has been observed as well. Cyanobacteria are known to generate a numerous variety of bioactive compounds. However, the versatile potential applications of cyanobacteria in biotechnology could be their significant growth rate and survival in severe environmental conditions due to their distinct and unique metabolic pathways as well as active defensive mechanisms. In this review, we elaborated on the versatile cyanobacteria applications in different areas of biotechnology. We also emphasized the factors that could impede the implementation to cyanobacteria applications in biotechnology and the execution of strategies to enhance their effective applications.

The evolutional development of the RNA translation process that leads to protein synthesis based on naturally occurring amino acids has its continuation via synthetic biology, the so-called rational bioengineering. Genetic code expansion (GCE) explores beyond the natural translational processes to further enhance the structural properties and augment the functionality of a wide range of proteins. Prokaryotic and eukaryotic ribosomal machinery have been proven to accept engineered tRNAs from orthogonal organisms to efficiently incorporate noncanonical amino acids (ncAAs) with rationally designed side chains. These side chains can be reactive or functional groups, which can be extensively utilized in biochemical, biophysical, and cellular studies. Genetic code extension offers the contingency of introducing more than one ncAA into protein through frameshift suppression, multi-site-specific incorporation of ncAAs, thereby increasing the vast number of possible applications. However, different mediating factors reduce the yield and efficiency of ncAA incorporation into synthetic proteins. In this review, we comment on the recent advancements in genetic code expansion to signify the relevance of systems biology in improving ncAA incorporation efficiency. We discuss the emerging impact of tRNA modifications and metabolism in protein design. We also provide examples of the latest successful accomplishments in synthetic protein therapeutics and show how codon expansion has been employed in various scientific and biotechnological applications.

Phosphonates derivatives are compounds of interests and are applied as drugs of, e.g., antibacterial antiviral activities, connected with their inhibitory activity towards different enzymes, which is related to the configuration of particular compound isomers. The biological synthesis of such molecules is the method of choice and can be carried out using enzymes or whole cells from organisms. Photobiocatalysts employed in the bioconversion of epoxymethyl dimethyl phosphonate are able to convert this substrate into a pure geometric isomer of the unsaturated product, dimethyl (1E)-3-hydroxyprop-1-enylphosphonate, which is a rare and expensive compound of high added value. Six different strains were screened towards dimethyl epoxy phosphonate and in the case of Synechococcus bigranulatus, over 99% conversion was achieved. The product structure was confirmed with Mass Spectroscopy (MS); ¹H, ¹³C, ³¹P, and 2D Nuclear Magnetic Resonance (NMR); and Infrared Spectroscopy (IR).

Phosphonates derivatives are compounds of interests and are applied as drugs of e.g. antibacterial antiviral activities, what is connected with their inhibitory activity towards different enzymes, what in turn is in the relation to the configuration of particular compounds izomers. Biological synthesis of such molecules is the method of choice and can be carried on with enzymes or whole cells of organisms. Photobiocatalysts employed in bioconversion of epoxy dimethyl phosphonate are able to convert this substrate into geometric isomers of the unsaturated product, which is classified as very rare and expensive compound of high added value. Six different strains were screened towards dimethyl epoxy phosphonate and in case of Synechococcus bigranulatus 99% of conversion degree was achieved. Product structure and yield of the reaction were confirmed with Mass Spectroscopy (MS); Nuclear Magnetic Resonance (NMR) of isotopes 1H, 13C, and 31P, 2D NMR; and Infrared Spectroscopy (IR).

Infectious diseases caused by viruses, bacteria, protozoans, and fungi continue to pose significant challenges globally, with transmission routes including person-to-person contact, animal vectors, and environmental exposure. Despite global efforts to control these diseases, limited studies and resource constraints in Ore, Nigeria, have led to increasing prevalence, highlighting the need for targeted public health interventions. This study aimed to determine the distribution of infectious diseases among patients attending General Hospital Ore, Odigbo, Nigeria. Serum samples from consenting patients were assayed for the presence of malaria parasites, human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), Salmonella infection, Helicobacter pylori infection, high vaginal swab (HVS) results, and urinary tract infections (UTIs). The subjects included 1900 males (38.8%) and 3000 females (61.2%). The overall prevalence rates were as follows: HIV (40%), malaria (35%), typhoid (37.5%), HBsAg (20%), H. pylori (6.3%), HVS (45%), and UTIs (10%). The high rates of infectious diseases observed in this study, compared to rates reported elsewhere, suggest the need to strengthen public health measures and infection prevention strategies in the area. In addition, routine screening for these diseases and early passive or active immunization for vaccine-preventable diseases are essential to further reduce the burden of these infections.